- Breaking News
- |
- Entertainment
- |
- Sports
- |
- Business
- |
- Politics
- |
- Science
- |
- Technology
- |
- Odd News
- |
- Health
- |
- Law
BANGALORE - India's biotech major Biocon Friday entered into a strategic tie-up with the US-based Amylin Pharmaceuticals to jointly produce a peptide hybrid molecule for treating diabetes.
BANGALORE/ CALIFORNIA - Biocon, Limited (NSE: BIOCON) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes.
WASHINGTON - It's not just the size of the waist, but also the size of fat cells that play a major role in determining a women's risk for type 2 diabetes, according to a long-range study by Swedish researchers.